These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K. Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423 [Abstract] [Full Text] [Related]
3. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. Tashkin DP, Donohue JF, Mahler DA, Huang H, Goodwin E, Schaefer K, Hanrahan JP, Andrews WT. Respir Med; 2009 Apr; 103(4):516-24. PubMed ID: 19208459 [Abstract] [Full Text] [Related]
4. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. van Noord JA, Aumann JL, Janssens E, Smeets JJ, Verhaert J, Disse B, Mueller A, Cornelissen PJ. Eur Respir J; 2005 Aug; 26(2):214-22. PubMed ID: 16055868 [Abstract] [Full Text] [Related]
6. Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients. Cazzola M, Noschese P, Salzillo A, De Giglio C, D'Amato G, Matera MG. Respir Med; 2005 May; 99(5):524-8. PubMed ID: 15823447 [Abstract] [Full Text] [Related]
7. Bronchodilator efficacy of tiotropium-formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD. Salvi S, Brashier B, Gothi D, Karkhanis V, Madas S, Gogtay J, Joshi J. Pulm Pharmacol Ther; 2014 Feb; 27(1):90-5. PubMed ID: 23752057 [Abstract] [Full Text] [Related]
8. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD. Voshaar T, Lapidus R, Maleki-Yazdi R, Timmer W, Rubin E, Lowe L, Bateman E. Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436 [Abstract] [Full Text] [Related]
9. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Donohue JF, Fogarty C, Lötvall J, Mahler DA, Worth H, Yorgancioglu A, Iqbal A, Swales J, Owen R, Higgins M, Kramer B, INHANCE Study Investigators. Am J Respir Crit Care Med; 2010 Jul 15; 182(2):155-62. PubMed ID: 20463178 [Abstract] [Full Text] [Related]
14. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Tashkin DP, Hanania NA, McGinty J, Denis-Mize K, Chaudry I. Adv Ther; 2009 Nov 15; 26(11):1024-34. PubMed ID: 19953349 [Abstract] [Full Text] [Related]
15. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial. Bölükbas S, Eberlein M, Eckhoff J, Schirren J. Eur J Cardiothorac Surg; 2011 Jun 15; 39(6):995-1000. PubMed ID: 20970351 [Abstract] [Full Text] [Related]
20. Rational timing of combination therapy with tiotropium and formoterol in moderate and severe COPD. Terzano C, Petroianni A, Conti V, Ceccarelli D, Graziani E, Sanduzzi A, D'Avelli S. Respir Med; 2008 Dec 15; 102(12):1701-7. PubMed ID: 18760583 [Abstract] [Full Text] [Related] Page: [Next] [New Search]